371 related articles for article (PubMed ID: 29169152)
21. Combined Aurora Kinase A and CHK1 Inhibition Enhances Radiosensitivity of Triple-Negative Breast Cancer Through Induction of Apoptosis and Mitotic Catastrophe Associated With Excessive DNA Damage.
Li C; Liao J; Wang X; Chen FX; Guo X; Chen X
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1241-1254. PubMed ID: 37393021
[TBL] [Abstract][Full Text] [Related]
22. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers.
Witkiewicz AK; Dasgupta A; Sammons S; Er O; Potoczek MB; Guiles F; Sotgia F; Brody JR; Mitchell EP; Lisanti MP
Cancer Biol Ther; 2010 Jul; 10(2):135-43. PubMed ID: 20431349
[TBL] [Abstract][Full Text] [Related]
23. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
24. Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells.
Michmerhuizen AR; Chandler B; Olsen E; Wilder-Romans K; Moubadder L; Liu M; Pesch AM; Zhang A; Ritter C; Ward ST; Santola A; Nyati S; Rae JM; Hayes D; Feng FY; Spratt D; Wahl D; Eisner J; Pierce LJ; Speers C
Front Endocrinol (Lausanne); 2020; 11():35. PubMed ID: 32117061
[TBL] [Abstract][Full Text] [Related]
25. Caveolin-1 knockdown is associated with the metastasis and proliferation of human lung cancer cell line NCI-H460.
Song Y; Xue L; Du S; Sun M; Hu J; Hao L; Gong L; Yeh D; Xiong H; Shao S
Biomed Pharmacother; 2012 Sep; 66(6):439-47. PubMed ID: 22898083
[TBL] [Abstract][Full Text] [Related]
26. [Effect of Caveolin-1 on growth and apoptosis of human breast carcinoma cell line Hs578T/Dox].
Zheng YM; Li F; Qi BJ; Wang XH; Sun HC; Liu S
Ai Zheng; 2009 Jun; 28(6):587-92. PubMed ID: 19635195
[TBL] [Abstract][Full Text] [Related]
27. The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy.
Zhou ZR; Yang ZZ; Wang SJ; Zhang L; Luo JR; Feng Y; Yu XL; Chen XX; Guo XM
Acta Pharmacol Sin; 2017 Apr; 38(4):513-523. PubMed ID: 28042876
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells.
You KS; Yi YW; Kwak SJ; Seong YS
Int J Oncol; 2018 Mar; 52(3):828-840. PubMed ID: 29344641
[TBL] [Abstract][Full Text] [Related]
29. CXCR4 antagonist AMD3100 enhances the response of MDA-MB-231 triple-negative breast cancer cells to ionizing radiation.
Zhou KX; Xie LH; Peng X; Guo QM; Wu QY; Wang WH; Zhang GL; Wu JF; Zhang GJ; Du CW
Cancer Lett; 2018 Apr; 418():196-203. PubMed ID: 29317253
[TBL] [Abstract][Full Text] [Related]
30. Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells.
Chen X; Ma N; Zhou Z; Wang Z; Hu Q; Luo J; Mei X; Yang Z; Zhang L; Wang X; Feng Y; Yu X; Ma J; Guo X
Med Sci Monit; 2017 Jun; 23():2674-2683. PubMed ID: 28570501
[TBL] [Abstract][Full Text] [Related]
31. TBRG4 silencing promotes progression of squamous cell carcinoma via regulation of CAV-1 expression and ROS formation.
Wang J; Luo Q; Liu M; Zhang C; Jia Y; Tong R; Yang L; Fu X
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):157-164. PubMed ID: 32415943
[TBL] [Abstract][Full Text] [Related]
32. Targeting PI3K and AMPKα Signaling Alone or in Combination to Enhance Radiosensitivity of Triple Negative Breast Cancer.
Johnson J; Chow Z; Napier D; Lee E; Weiss HL; Evers BM; Rychahou P
Cells; 2020 May; 9(5):. PubMed ID: 32438621
[TBL] [Abstract][Full Text] [Related]
33. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.
Shang ZF; Wei Q; Yu L; Huang F; Xiao BB; Wang H; Song M; Wang L; Zhou J; Wang J; Li S
Oncotarget; 2016 Sep; 7(38):62340-62351. PubMed ID: 27694690
[TBL] [Abstract][Full Text] [Related]
34. The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints.
Mei Z; Su T; Ye J; Yang C; Zhang S; Xie C
Radiat Res; 2015 Feb; 183(2):196-207. PubMed ID: 25594541
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation.
Wischmann FJ; Troschel FM; Frankenberg M; Kemper B; Vijaya Kumar A; Sicking M; Ibrahim SA; Kiesel L; Götte M; Eich HT; Greve B
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8455-8465. PubMed ID: 37088795
[TBL] [Abstract][Full Text] [Related]
36. Targeting survivin sensitizes cervical cancer cells to radiation treatment.
Zhou J; Guo X; Chen W; Wang L; Jin Y
Bioengineered; 2020 Dec; 11(1):130-140. PubMed ID: 31959045
[TBL] [Abstract][Full Text] [Related]
37. MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer.
Kim YJ; Choi JS; Seo J; Song JY; Lee SE; Kwon MJ; Kwon MJ; Kundu J; Jung K; Oh E; Shin YK; Choi YL
Int J Cancer; 2014 May; 134(10):2424-36. PubMed ID: 24615768
[TBL] [Abstract][Full Text] [Related]
38. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
[TBL] [Abstract][Full Text] [Related]
39. Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair.
Codenotti S; Marampon F; Triggiani L; Bonù ML; Magrini SM; Ceccaroli P; Guescini M; Gastaldello S; Tombolini V; Poliani PL; Asperti M; Poli M; Monti E; Fanzani A
Cancer Lett; 2021 May; 505():1-12. PubMed ID: 33610729
[TBL] [Abstract][Full Text] [Related]
40. Cathepsin L suppression increases the radiosensitivity of human glioma U251 cells via G2/M cell cycle arrest and DNA damage.
Zhang QQ; Wang WJ; Li J; Yang N; Chen G; Wang Z; Liang ZQ
Acta Pharmacol Sin; 2015 Sep; 36(9):1113-25. PubMed ID: 26095040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
